Grant: Master's Award: Canada Graduate Scholarships
University of Manitoba
$17,500.00
Role of Sirtuin-3 deficiency in the development of gestational diabetes.
FY 2023-24
Summary
Diabetes in Canada continues to rise with rates higher than ever before that are posing overwhelming costs to the healthcare system. Gestational diabetes (GDM) is a type of diabetes that occurs when the mother’s blood glucose levels are too high during pregnancy. GDM is the most common type of pregnancy complication. GDM is associated with premature birth, birth injuries and larger babies. GDM also increases the risk of developing type 2 diabetes, obesity, and cardiovascular disease in mothers and their children. Despite these serious health implications, little is known about the precise factors that lead to the development of GDM. Mitochondria are the main energy producing organelles of the cell and mitochondrial dysfunction in association with accumulation of fat in the liver has recently been observed in women diagnosed with GDM. Sirtuin-3 (SIRT3) is a mitochondrial localized protein that is a key regulator of energy metabolism and has been shown to be reduced in women with GDM. Our lab recently discovered that SIRT3 expression is reduced in the liver of GDM mice. This project aims to uncover the role of SIRT3 in the development of GDM. Using a mouse lacking SIRT3 in the liver, we will evaluate how SIRT3 deficiency affects blood glucose levels during pregnancy. We will also assess whether SIRT3 deficiency impairs liver mitochondrial function and results in the accumulation of fat in the liver during pregnancy. Understanding the role of SIRT3 will contribute to future studies determining whether activation of SIRT3 improves maternal metabolic health during pregnancy.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Manitoba, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
506247
Name
Trivedi Khushali
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Role of Sirtuin-3 deficiency in the development of gestational diabetes.
Programtype2
Studentship Programs
Orgnameinp2
University of Manitoba
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Child And Maternal Health; Diabetes; Gestational Diabetes Mellitus; Hepatic Steatosis; Insulin Resistance; Metabolic Dysfunction; Mitochondria; Mitochondrial Dysfunction; Obesity; Pregnancy
Abstract
Diabetes in Canada continues to rise with rates higher than ever before that are posing overwhelming costs to the healthcare system. Gestational diabetes (GDM) is a type of diabetes that occurs when the mother’s blood glucose levels are too high during pregnancy. GDM is the most common type of pregnancy complication. GDM is associated with premature birth, birth injuries and larger babies. GDM also increases the risk of developing type 2 diabetes, obesity, and cardiovascular disease in mothers and their children. Despite these serious health implications, little is known about the precise factors that lead to the development of GDM. Mitochondria are the main energy producing organelles of the cell and mitochondrial dysfunction in association with accumulation of fat in the liver has recently been observed in women diagnosed with GDM. Sirtuin-3 (SIRT3) is a mitochondrial localized protein that is a key regulator of energy metabolism and has been shown to be reduced in women with GDM. Our lab recently discovered that SIRT3 expression is reduced in the liver of GDM mice. This project aims to uncover the role of SIRT3 in the development of GDM. Using a mouse lacking SIRT3 in the liver, we will evaluate how SIRT3 deficiency affects blood glucose levels during pregnancy. We will also assess whether SIRT3 deficiency impairs liver mitochondrial function and results in the accumulation of fat in the liver during pregnancy. Understanding the role of SIRT3 will contribute to future studies determining whether activation of SIRT3 improves maternal metabolic health during pregnancy.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Trivedi, Khushali
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~